180 Life Sciences granted extension by Nasdaq to regain compliance with continued listing requirements No summary available.
180 Life Sciences Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements PALO ALTO, Calif., July 02, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced that it received notice from the Nasdaq Listing Qualifications Panel (the “Hearings Panel”) of The Nasdaq Stock Market LLC (“Nasdaq”) that the Hearings Panel has determined to grant the Company's request to continue its listing on The Nasdaq Stock Market, subject to the Company meeting certain conditions, including filing on or before July 31, 2024, a public disclosure describing the transactions undertaken by the Company to achieve compliance with Nasdaq's continued listing rules and demonstrate long-term compliance with the Equity Rule (defined below) and providing an indication of its equity following those transactions.
ATNF Stock Earnings: 180 Life Sciences Reported Results for Q1 2024 180 Life Sciences (NASDAQ: ATNF ) just reported results for the first quarter of 2024. 180 Life Sciences reported earnings per share of -$1.68. The company did not report any revenue for the quarter. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. It doesn’t matter if you have $500 or $5 million. Do this now. The post ATNF Stock Earnings: 180 Life Sciences Reported Results for Q1 2024 appeared first on InvestorPlace .
180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement PALO ALTO, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced that the Company received a letter on March 13, 2024 from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company has regained full compliance with the minimum bid price for continued listing on the Nasdaq pursuant to Nasdaq Listing Rule 5550(a)(2) (“Minimum Bid Price Requirement”).
180 Life Sciences Corp board member Sir Marc Feldmann resigns https://www.investing.com/news/stock-market-news/180-life-sciences-corp-board-member-sir-marc-feldmann-resigns-93CH-3332270
180 Life Sciences Appoints Blair Jordan as Board Director 180 Life Sciences (ATNF) has provided an announcement. 180 Life Sciences Corp. has welcomed Blair Jordan to its Board as a Class II director, effec…
180 Life Sciences announces 1-for-19 reverse stock split https://www.investing.com/news/stock-market-news/180-life-sciences-announces-1for19-reverse-stock-split-93CH-3315614
180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance Plan PALO ALTO, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-19 (the “Reverse Stock Split”). The Reverse Stock Split is expected to become effective on February 28, 2024 at 12:01 p.m. Eastern Time (the “Effective Time”), with shares expected to begin trading on the Nasdaq Capital Market, on a split-adjusted, at market open on February 28, 2024. In connection with the Reverse Stock Split, every 19 shares of the Company's common stock issued and outstanding as of the Effective Time will be automatically converted into one share of the Company's common stock. No change will be made to the trading symbol for the Company's shares of common stock or public warrants, “ATNF” and “ATNFW”, respectively, in connection with the reverse split.
180 Life Sciences Wins Interim Legal Cost Coverage Ruling 180 Life Sciences (ATNF) has released an update. A recent court ruling has favored 180 Life Sciences Corp. in its litigation by ordering two insure…